Titel	Veröffentlichungsdatum	Sprache	Zitate
Health-Related Quality of Life Measured with EQ-5D in Patients Treated for Depression in Primary Care	2007/03/01	English	112
German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus	2008/07/01	English	111
Measuring Patient Preferences for Colorectal Cancer Screening Using a Choice-Format Survey	2007/09/01	English	111
Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries: Applying a Standardized Costing Methodology	2012/01/01	English	109
Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses	2006/07/01	English	109
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report	2017/07/01	English	109
Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan	2017/03/01	English	109
Italian Population-Based Values of EQ-5D Health States	2013/07/01	English	109
US Valuation of Health Outcomes Measured Using the PROMIS-29	2014/12/01	English	108
Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese Population	2008/03/01	English	108
Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development	2018/07/01	English	107
Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods	2009/07/01	English	107
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II	2010/01/01	English	107
The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons	2008/05/01	English	107
Defining Patient-Reported Outcomes	2004/09/01	English	105
A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders	2012/01/01	English	105
The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope	2013/09/01	English	104
A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]	2018/02/01	English	103
Development and Validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)©	2008/09/01	English	102
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies	2018/07/01	English	102
Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data	2009/01/01	English	102
Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation	2013/06/01	English	102
Computer Modeling of Diabetes and Its Complications: A Report on the Fifth Mount Hood Challenge Meeting	2013/06/01	English	101
Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D	2010/12/01	English	100
Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group	2013/07/01	English	100
Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer	2004/03/01	English	99
Is Management Essential to Improving the Performance and Sustainability of Health Care Systems and Organizations? A Systematic Review and a Roadmap for Future Studies	2013/01/01	English	99
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies	2016/09/01	English	99
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report	2016/09/01	English	99
Cost-Effectiveness of Face-to-Face Smoking Cessation Interventions: A Dynamic Modeling Study	2005/05/01	English	99